Concord Biotech Ltd.

NSE: CONCORDBIO | BSE: 543960

Expensive Performer

Download real time

1353.80 10.50 (0.78%)

36.92% Fall from 52W High

396.2K

NSE+BSE Volume

NSE 12 Jun, 2026 3:31 PM (IST)

-

Beta 1Year

Low volatility

US FDA Approval

Concord Biotech's ANDA for Tofacitinib Tablets gets US FDA nod, with a market size of $500 mn See details

Concord Biotech RSI, Moving Averages, Technical Analysis MACD, MFI, Stochastic and Candlesticks

Concord Biotech technical analysis - SMA, EMA, Price Change analysis, 52 Week high low, Beta and volume delivery analysis